drugset / Trial / NCT02156492
A Study of Evacetrapib With Selected Statins in Healthy Chinese Participants
RandomizedParallel-groupOpen-labelBasic science
Summary
The main purpose of this study is to investigate how the body responds to evacetrapib and to evaluate the safety and the effect of evacetrapib, alone and in combination with selected statins, in healthy Chinese participants. The study has 2 parts. Part one will last up to 4 weeks and part two will last up to 5 weeks, not including screening. Participants may only enroll in one part.
Timeline
- Start
- 2014-06
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | — | Oral |
| Subject | Evacetrapib | Small molecule | 130 mg | Oral |
| Subject | Simvastatin | Small molecule | — | Oral |
Indications
No indication recorded.